Overview

Anisodamine Critically Ill SeptIc Shock

Status:
Completed
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
Anisodamine has been widely used in China for its pharmacological effect on improving microcirculation during shock. It has been reported that anisodamine is effective in reducing mortality rate in children with meningitis. however, its effectiveness in patients with septic shock has not been systematically investigated. The aim of the study is to investigate the effectiveness of anisodamine in the treatment of patients with septic shock.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Jinhua Central Hospital
Treatments:
Anisodamine